During the past decade, Toledo Clinic Cancer Centers-Bowling Green conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 61 clinical trials were completed, i.e. on average, 1220% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 26 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toledo Clinic Cancer Centers-Bowling Green" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "SWOG Cancer Research Network" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "GOG Foundation" with 5 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toledo Clinic Cancer Centers-Bowling Green" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Toledo Clinic Cancer Centers-Bowling Green" are "Recurrent Breast Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (5 trials), "Breast Cancer" (4 trials), "Clear Cell Renal Cell Carcinoma" (4 trials) and "Stage IIA Breast Cancer AJCC v6 and v7" (4 trials). Many other conditions were trialed in "Toledo Clinic Cancer Centers-Bowling Green" in a lesser frequency.

Most popular intervention types in "Toledo Clinic Cancer Centers-Bowling Green" are "Drug" (69 trials), "Other" (55 trials), "Biological" (38 trials), "Radiation" (8 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (43 trials), "Quality-of-Life Assessment" (20 trials), "Bevacizumab" (15 trials), "Paclitaxel" (11 trials) and "Carboplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Toledo Clinic Cancer Centers-Bowling Green" are 61 trials for "All" genders, 13 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Toledo Clinic Cancer Centers-Bowling Green". undefined are not yet recruiting, 1 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Toledo Clinic Cancer Centers-Bowling Green, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Toledo Clinic Cancer Centers-Bowling Green, 4 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".